financetom
Business
financetom
/
Business
/
Fanhua BluePlus Partners With Shanghai Biotecan for New Health Services
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Fanhua BluePlus Partners With Shanghai Biotecan for New Health Services
Sep 6, 2024 4:43 AM

07:02 AM EDT, 09/06/2024 (MT Newswires) -- Fanhua ( FANH ) said Friday its subsidiary Fanhua BluePlus Health Management is partnering with Shanghai Biotecan Pharmaceuticals to provide new health management services.

The companies will collaborate on areas including medical testing, health management and cell therapy, Fanhua ( FANH ) said.

Finance details of the partnership were not disclosed.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
What's Going On With SunPower Stock?
What's Going On With SunPower Stock?
Jun 7, 2024
SunPower Corporation ( SPWR ) shares are trading higher Friday amid another surge in meme stocks in anticipation of a livestream scheduled on Roaring Kitty's YouTube channel. The Details: Keith Gill, a.k.a. Roaring Kitty, posted a screenshot of what is believed to be his very large position in GameStop on Sunday and on Thursday a livestream was scheduled on the...
What's Going On With United Airlines Shares Friday?
What's Going On With United Airlines Shares Friday?
Jun 7, 2024
United Airlines Holdings, Inc. ( UAL ) shares are trading flat Friday. The company recently announced the launch of its new media network. What Happened: On Friday morning, United Airlines announced its media network entitled Kinective, the first media network to use travel insights for personalized, real-time ads, content and offers from top brands. Kinective enables companies to market its...
COVID shots should target JN.1 variants in 2024-25 campaign, US FDA says
COVID shots should target JN.1 variants in 2024-25 campaign, US FDA says
Jun 7, 2024
June 7 (Reuters) - The U.S. Food and Drug Administration on Friday advised COVID-19 vaccine manufacturers that new shots for the fall 2024 campaign should target the JN.1 variant that was dominant earlier this year. ...
EXPLAINER-Why the few big AI players worry US antitrust regulators
EXPLAINER-Why the few big AI players worry US antitrust regulators
Jun 7, 2024
* Data access and labor market control spark concerns * AI partnerships under scrutiny By Jody Godoy NEW YORK, June 7 (Reuters) - U.S. antitrust enforcers are digging into Big Tech's role in the artificial intelligence (AI) boom, exploring whether business practices by entrenched players stifle competition in the burgeoning space. The U.S. Department of Justice and Federal Trade Commission...
Copyright 2023-2026 - www.financetom.com All Rights Reserved